I am a clinical doctor specialized on internal medicine and Infectious and Tropical Diseases. My training has been completed by a PhD in Public Health and Epidemiology, pharmacovigilance training, Master’s degree of Science in human pathology (Méditerranée-Aix-Marseille II university), university diploma in “management of anti-infectious drug” and by field experience. In Cameroon, I worked as physician in charge of the adult sector and of the laboratory in a small district hospital in the Far North of Cameroon close to the Nigerian border for two years. In France, I worked during two years as Head of clinic in Infectious and Tropical Diseases department at Hôpital Saint-Louis (Paris), specialized in HIV-hepatitis and infectious disease in immunosuppressed patients including hematology (bone marrow transplant). I joined Institut Pasteur in 2013, first in the Center of Translational Science and in the Emerging Disease Epidemiology unit. I developed clinical research projects in collaboration with institutes of the Institut Pasteur International Network and provide methodological support to research teams at Institut Pasteur. Then, I was in charge of clinical research at the Pasteur Institute of Dakar. I led several clinical research projects, including clinical trials. I was leader or co-leader of European projects (EDCTP) in the areas of emerging and re-emerging diseases (ALERRT) and ethics (SEA-RAFES). I’m member of Institutional Review Board of Institut Pasteur. Currently I’m working at the Institut Pasteur Medical Center as clinician and responsible of clinical research.
Click to view graph
Connections
Click to view timeline
Timeline
Transversal Projects
Projects
Former Teams
Publications
Download-
2024Snakebites in Cameroon by Species Whose Effects Are Poorly Described., Trop Med Infect Dis 2024 Dec; 9(12): .
-
2024Monkeypox clade IIb in France in 2023-2024., Lancet Reg Health Eur 2024 Dec; 47(): 101114.
-
2024Increased incidence of diabetes in people living with HIV treated with first-line integrase strand transfer inhibitors: A French multicentre retrospective study., HIV Med 2024 Aug; (): .
-
2024Health problems and exposure to infectious risks in returning humanitarian aid workers., J Travel Med 2024 Jul; 31(5): .
-
2024Snakebites in Cameroon: Tolerance of a Snake Antivenom (Inoserp™ PAN-AFRICA) in Africa in Real-Life Conditions., Toxins (Basel) 2024 Mar; 16(4): .
-
2024High pertussis circulation among infants, children and adolescents in Abidjan, Côte d’Ivoire., PLoS One 2024 ; 19(11): e0310965.
-
2023Real life condition evaluation of Inoserp PAN-AFRICA antivenom effectiveness in Cameroon., PLoS Negl Trop Dis 2023 Nov; 17(11): e0011707.
-
2023Antibody Titers in Elderly Patients After Rabies Post-Exposure Prophylaxis., Clin Infect Dis 2023 Nov; 77(10): 1486-1487.
-
2023Injecting drug use increases the risk of death in HIV patients on antiretroviral therapy in Vietnam., AIDS Care 2023 Jun; (): 1-10.
-
2023Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals., Cell Host Microbe 2023 Jun; 31(6): 937-948.e4.
-
+View full list of publications